Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significance
- 1 December 1997
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 18 (6) , 550-556
- https://doi.org/10.1016/s0197-2456(97)00075-5
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Testing the Hypothesis that Matters for Multiple Primary EndpointsDrug Information Journal, 1996
- Biostatistical methodology in clinical trials in applications for marketing authorizations for medicinal products. CPMP working party on efficacy of medicinal products note for guidance III/3630/92‐ENStatistics in Medicine, 1995
- A comment on replication,P‐values and evidenceStatistics in Medicine, 1992
- Sample sizes for constructing confidence intervals and testing hypothesesStatistics in Medicine, 1989